Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04576156
Brief Title: A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

First Submitted : September 18, 2020
First Submitted that Met QC Criteria : October 2, 2020
First Posted : October 6, 2020

Last Update Submitted that Met QC Criteria : December 2, 2021
Last Update Posted : December 6, 2021